Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

Facility Amendment and Funding Update

11 Jun 2025 07:00

RNS Number : 2937M
Supply@ME Capital PLC
11 June 2025
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

11 June 2025

Supply@ME Capital plc

(The "Company" or "SYME")

Facility Amendment and Funding Update

 

SYME, the fintech business which provides an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow, announces the following update in respect of the US$5,150,000 on-demand convertible funding facility agreed on 18 March 2025 with Nuburu Inc., a NYSE listed (NYSE American: BURU) high-tech company of which Alessandro Zamboni, a director of the Company, is Executive Chairman ("BURU") (the "New On-Demand Facility").

Subsequent to the announcement made by the Company dated 2 June 2025, the Company received an additional US$130,000 from BURU, leaving US$2,000,000 to still be received in respect of the unpaid April 2025 and May 2025 instalments under the original terms of the New On-Demand Facility.

The latest communication that the board of directors of SYME has had with BURU, via Alessandro Zamboni, is that BURU expects to complete shortly the necessary regulatory approvals including, inter alia, the effectiveness of the S-1 registration statement recently filed with the US Securities and Exchange Commission. This will allow BURU to use the Stand-by Purchase Agreement (the "SEPA") signed with YA II PN, LTD. (a fund managed by Yorkville Advisors) on 30 May 2025 to raise the capital to complete its strategic investments and meet its commitments to the Company under the New-On Demand Facility.

In light of the delays to the payment of the April 2025 and May 2025 tranches under the original New On-Demand Facility, the expected timing of the BURU regulatory approvals and BURU's plan with regards to the timing and use of funds under the SEPA drawdowns, the Company entered into an amendment to the New On-Demand Facility with BURU on 10 June 2025 (the "Amendment") which amends the following key terms of the New On-Demand Facility:

1) The remaining total amount of US $4,500,000 will now be received by the Company in line with the following tranches:

- US $300,000 on or before 23 June 2025;

- US $1,200,000 on or before 15 July 2025;

- US $500,000 on or before 30 July 2025;

- US $1,000,000 on or before 31 August 2025; and

- US $1,500,000 on or before 20 September 2025. 

2) In order for the Company to be able to issue the new ordinary shares under the New On-Demand Facility, approvals will be required from the shareholders of the Company, the Financial Conduct Authority (the "FCA") and The Panel on Takeovers and Mergers (together the "Approvals"). The Amendment has amended the date by which the Approvals must be obtained by the Company from 30 September 2025 to 31 March 2026. If the Approvals are not obtained by 31 March 2026, BURU can demand repayment in cash, and the Company is required to provide security over the intellectual property rights and receivables related to its Italian subsidiary entities in favour of BURU.

3) Interest will accrue daily at the federal funds rate set out by the Federal Open Market Committee of the US Federal Reserve from time to time plus 10%. Under the Amendment, the interest is no longer payable quarterly in arrears in cash, but any interest accrued and outstanding at the date of any conversion notice issued by BURU (subject to the Approvals having been obtained) will be the added to the amount in the conversion notice.

All other key terms to the New On-Demand Facility that were set out in the Company's announcement dated 19 March 2025 remain unchanged.

It should be noted that the heads of terms agreement that the Company entered into with BURU on 18 March 2025 (the "Heads of Terms") have not been amended. The key actions under the Heads of Terms can be found in the announcement made by the Company on 19 March 2025.

Alessandro Zamboni, the Chief Executive Officer of the Company, is a related party in connection with the Amendment due to the fact that he is also the Executive Chairman of BURU. As such, the entry by the Company into the Amendment constitutes a material related party transaction for the purpose of DTR 7.3 and was, accordingly, voted upon by the independent Directors (excluding Alessandro Zamboni, who, constituted a "related party" (as such term is defined in IFRS). The independent Directors consider the material related party transaction in respect of the Amendment to be fair and reasonable from the perspective of the Company and its shareholders who are not a related party or otherwise interested in BURU.

Following the completion of the Amendment, the Company will continue to work with its auditors to finalise the Annual Report and Accounts for the year ended 31 December 2024 (the "2024 Annual Report"), and, once the 2024 Annual Report has been published, make an application to the FCA for the temporary suspension of the Company's shares from the Official List and from trading on the London Stock Exchange to be lifted. Following the publication of the 2024 Annual Report, the Company also expects to announce the date on which it plans to hold its next Annual General Meeting.

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of SYME is Alessandro Zamboni, CEO.

Notes

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehoused goods waiting to be sold to end-customers or goods that are part of a typical import/export transaction.

Contacts

Albert Ganyushin, Chairman, Supply@ME Capital plc, investors@supplymecapital.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFEIRRIILIE
Date   Source Headline
28th Apr 20267:00 amRNSExercise of Open Offer Warrants
27th Apr 20267:00 amRNSDelay in publishing 2025 Annual Financial Report
10th Apr 20267:00 amRNSExercise of Open Offer Warrants
16th Jan 20267:00 amRNSExercise of Open Offer Warrants
6th Jan 20267:00 amRNSProposed acquisition - Heads of Terms
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
5th Dec 202511:05 amRNSResults of AGM and Directorate Change
19th Nov 20257:00 amRNSBusiness update
6th Nov 20257:00 amRNSNotice of AGM
23rd Oct 20258:08 amRNSRestoration of Listing and Trading
23rd Oct 20257:30 amRNSRestoration - Supply@Me Capital plc
20th Oct 20257:00 amRNSFunding update
14th Oct 20257:00 amRNSH1 2025 unaudited interim report and accounts
13th Oct 20257:00 amRNS2024 Annual Report and Accounts
29th Sep 20257:00 amRNSDelay in publication of the H12025 interim results
18th Sep 20257:00 amRNSFunding update
15th Sep 20252:32 pmRNSFunding update
1st Sep 20257:00 amRNSFacility Amendment and Funding Update
31st Jul 20257:00 amRNSFunding update
16th Jul 20257:00 amRNSFunding update
2nd Jul 202512:00 pmRNSFunding update
24th Jun 20257:00 amRNSFunding update
11th Jun 20257:00 amRNSFacility Amendment and Funding Update
2nd Jun 20257:00 amRNSFunding Update
6th May 20257:00 amRNSPDMR Resignation
1st May 20257:00 amRNSFunding update
28th Apr 20257:00 amRNSDelay in published 2024 Annual Report and Accounts
1st Apr 202510:58 amRNSFunding update
19th Mar 20257:00 amRNSNew Funding Facility
14th Feb 20257:00 amRNSAppointment of new auditor
10th Feb 20257:00 amRNSFunding update
20th Jan 20257:00 amRNSDirector’s Other External Appointments
17th Dec 20247:00 amRNSBusiness Update
30th Sep 20242:45 pmRNSUnaudited interim results
25th Sep 20247:00 amRNSResignation of Auditor
6th Sep 20247:00 amRNSDirectorate Change
9th Jul 20247:00 amRNSExercise of Open Offer Warrants
28th Jun 20249:22 amRNSResult of AGM
31st May 202411:14 amRNSHolding(s) in Company
31st May 20247:00 amRNSTotal Voting Rights
29th May 20244:58 pmRNSNotice of Annual General Meeting
21st May 20247:00 amRNSStrategic alliance with p-Chip Corporation
15th May 20247:00 amRNSNew equity funding secured for £1,552,500
10th May 202411:47 amRNSPublication of the 2023 Annual Report and Accounts
9th May 20245:02 pmRNSIndependent Auditor's Report
1st May 20247:00 amRNS2023 Annual Report and Accounts
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.